Research Report on Lancets Market Globally strategic overview Lancets Market | Page 2

Asia Pacific to dominate the Lancets Market during the forecast period
In 2018, North America dominated the Lancets Market, followed by Europe. Increasing
prevalence of diabetes and favorable reimbursement scenario in the region are the factors
propelling the growth of the market in the region.
The Asia Pacific region is projected to register the highest growth rate in the global Lancets
Market during the forecast period. This is primarily attributed to the rapid economic growth,
rising awareness about diabetes treatment, rising geriatric population in China and India, and
Japan’s growing healthcare industry.
Prominent players in the Lancets Market are Becton, Dickinson and Company (US), Roche
Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo
Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt
(Germany), and SteriLance Medical (Suzhou) (China).
Browse Related Reports:
Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length
(4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and
Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023
Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose
Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare),
Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022
Blood Collection Market by Product (Serum Tube, Plasma Tube, EDTA, Heparin, Coagulation,
Glucose, Needle, Lancet, ESR, Syringe, Blood Bag), Method (Manual, Automated), End User
(Hospital, Blood Bank Center, Academics, Home Care) - Global Forecast to 2022
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries worldwide approach
MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims at proactive
collaboration with the clients to identify new opportunities, identify most important customers,
write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both
the company and its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments. MarketsandMarkets™ is
determined to benefit more than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by providing them research ahead
of the curve.